Published in

American Society of Hematology, Blood, 8(123), p. 1121-1123

DOI: 10.1182/blood-2014-01-546986



Export citation

Search in Google Scholar

SLPI is essential for granulopoiesis

Journal article published in 2014 by Martijn A. Nolte ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO


In this issue of Blood, Klimenkova et al demonstrate that secretory leukocyte protease inhibitor (SLPI), the natural inhibitor of neutrophil elastase (NE), plays a nonredundant role in human neutrophil differentiation. The authors show that NE itself is both required and sufficient to induce expression of SLPI in myeloid progenitors, which subsequently regulates granulocyte colony-stimulating factor receptor (G-CSFR) signaling and thereby cell proliferation, differentiation, and survival. Patients with severe congenital neutropenia (SCN) were found to have strongly reduced SLPI levels, and this article contributes to unraveling the molecular mechanism(s) underlying the block in neutrophil formation in this disease.